MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest

MDxHealth SA (NASDAQ:MDXH) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 31,100 shares, an increase of 133.8% from the February 13th total of 13,300 shares. Currently, 0.2% of the company’s shares are short sold. Based on an average daily volume of 113,500 shares, the short-interest ratio is presently 0.3 days.

MDxHealth Price Performance

MDXH stock opened at $1.48 on Friday. The company has a debt-to-equity ratio of 3.14, a quick ratio of 1.45 and a current ratio of 1.54. MDxHealth has a 52 week low of $1.35 and a 52 week high of $3.50. The firm’s fifty day moving average is $1.85 and its 200 day moving average is $2.08. The firm has a market cap of $69.99 million, a P/E ratio of -0.97 and a beta of 1.37.

MDxHealth (NASDAQ:MDXH) last released its earnings results on Wednesday, February 26th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.07. The company had revenue of $24.74 million for the quarter, compared to analyst estimates of $22.67 million. MDxHealth had a negative net margin of 49.52% and a negative return on equity of 1,077.84%. Research analysts predict that MDxHealth will post -1.15 earnings per share for the current year.

Institutional Investors Weigh In On MDxHealth

A number of large investors have recently added to or reduced their stakes in MDXH. Samjo Management LLC grew its holdings in MDxHealth by 130.9% in the 4th quarter. Samjo Management LLC now owns 1,824,312 shares of the company’s stock worth $4,324,000 after acquiring an additional 1,034,312 shares during the last quarter. AWM Investment Company Inc. grew its holdings in MDxHealth by 11.1% in the 4th quarter. AWM Investment Company Inc. now owns 4,721,290 shares of the company’s stock worth $11,189,000 after acquiring an additional 471,290 shares during the last quarter. Northern Trust Corp bought a new stake in MDxHealth in the 4th quarter worth $1,033,000. Perkins Capital Management Inc. grew its holdings in MDxHealth by 31.6% in the 4th quarter. Perkins Capital Management Inc. now owns 983,475 shares of the company’s stock worth $2,331,000 after acquiring an additional 236,100 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in shares of MDxHealth by 715.2% in the 4th quarter. Renaissance Technologies LLC now owns 123,100 shares of the company’s stock worth $292,000 after purchasing an additional 108,000 shares during the period.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.